Our results confirmed the activation of DNMT1 by HIV in vivo, and reported for the first time a marked up-regulation of DNMT3a and DNMT3b in HIV-positive aggressive B-cell lymphomas. The gene discussed is DNMT1; the disease is B-cell non-Hodgkin lymphoma.